Table 5. Comparison of studied data according to PACE4genotypes in all OA cases.
| OA(n=432) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| PACE4 rs4965833 | AA (n=175) | AG (n=185) | GG (n=70) | P | AG+GG (n=255) | P | AA+AG (n=360) | P | |
| Affected leg | Left/right, n | 116/59 | 123/62 | 48/22 | 0.938 | 171/84 | 0.867 | 239/121 | 0.723 |
| ESR, mm/h | SD ± SEM | 17.93 ± 16.60 | 17.04 ± 13.32 | 16.86 ± 13.83 | 0.809 | 16.99 ± 13.43 | 0.518 | 17.48 ± 14.99 | 0.750 |
| CRP, mg/L | SD ± SEM | 18.98 ± 17.52 | 17.30 ± 14.36 | 20.35 ± 22.77 | 0.400 | 18.14 ± 17.09 | 0.619 | 18.12 ± 15.97 | 0.322 |
| VAS | SD ± SEM | 6.53 ± 1.40 | 6.49 ± 1.42 | 6.56 ± 1.16 | 0.932 | 6.51 ± 1.35 | 0.873 | 6.51 ± 1.41 | 0.798 |
| Lequesnes’ index | SD ± SEM | 14.79 ± 1.82 | 14.64 ± 1.78 | 14.93 ± 1.69 | 0.463 | 14.72 ± 1.76 | 0.662 | 14.71 ± 1.80 | 0.357 |
| KL grading | III+IV/II, n | 31/144 | 41/144 | 8/62 | 0.134 | 206/49 | 0.694 | 288/72 | 0.092 |